| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IJROBP.2005.03.073 |
| P698 | PubMed publication ID | 16115740 |
| P2093 | author name string | Mark Williams | |
| Lech Papiez | |||
| Robert D Timmerman | |||
| Ronald C McGarry | |||
| Tia Whitford | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung carcinoma | Q18556110 |
| non-small-cell lung carcinoma | Q3658562 | ||
| P304 | page(s) | 1010-1015 | |
| P577 | publication date | 2005-08-22 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study | |
| P478 | volume | 63 |
| Q33973367 | 18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy |
| Q36554195 | A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). |
| Q41962669 | A comparison of the different 3D CT scanning modes on the GTV delineation for the solitary pulmonary lesion |
| Q83366949 | A method for improved verification of entire IMRT plans by film dosimetry |
| Q33664774 | A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy |
| Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
| Q35129122 | Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer |
| Q33645619 | Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy |
| Q35200640 | Alternative to surgery in early stage NSCLC-interventional radiologic approaches |
| Q37767616 | Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time? |
| Q37251404 | An evaluation of planning techniques for stereotactic body radiation therapy in lung tumors |
| Q40211983 | An initial study on the estimation of time-varying volumetric treatment images and 3D tumor localization from single MV cine EPID images |
| Q36258261 | Beam's-eye-view imaging during non-coplanar lung SBRT. |
| Q35302530 | Causal effects of time-dependent treatments in older patients with non-small cell lung cancer |
| Q35150641 | Clinical analysis of stereotactic body radiation therapy using extracranial gamma knife for patients with mainly bulky inoperable early stage non-small cell lung carcinoma |
| Q30463708 | Clinical application of CyberKnife for high-risk central nervous system tumors: A clinical trial report of 60 cases |
| Q30570350 | Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases. |
| Q35290324 | Clinical outcomes of cyberknife stereotactic radiosurgery for lung metastases |
| Q35812234 | Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer |
| Q83660718 | Comparisons of dose-volume histograms for proton-beam versus 3-D conformal x-ray therapy in patients with stage I non-small cell lung cancer |
| Q80100617 | Conformal high dose external radiation therapy, 80.5 Gy, alone for medically inoperable non-small cell lung cancer: a retrospective analysis |
| Q36767669 | Current status of stereotactic body radiotherapy for lung cancer |
| Q34331400 | CyberKnife for hilar lung tumors: report of clinical response and toxicity |
| Q33698367 | CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment |
| Q35972485 | CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Stage I Non-Small Cell Lung Cancer |
| Q35796322 | Definitive Treatment of Early-Stage Non-Small Cell Lung Cancer with Stereotactic Ablative Body Radiotherapy in a Community Cancer Center Setting |
| Q35234046 | Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer |
| Q44560526 | Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy |
| Q40176468 | Dose differences in intensity-modulated radiotherapy plans calculated with pencil beam and Monte Carlo for lung SBRT. |
| Q37789035 | Early detection and screening of lung cancer |
| Q37139059 | Effective Rat Lung Tumor Model for Stereotactic Body Radiation Therapy |
| Q47826009 | Effects of collimator angle, couch angle, and starting phase on motion-tracking dynamic conformal arc therapy (4D DCAT). |
| Q27015651 | Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice |
| Q33326998 | Endovascular coils as lung tumour markers in real-time tumour tracking stereotactic radiotherapy: preliminary results |
| Q61450341 | Evaluation of plan quality and treatment efficiency for single-isocenter/two-lesion lung stereotactic body radiation therapy |
| Q34076575 | Evaluation of tumor motion effects on dose distribution for hypofractionated intensity-modulated radiotherapy of non-small-cell lung cancer. |
| Q37392508 | Extracranial stereotactic body radiotherapy. Review of main SBRT features and indications in primary tumors |
| Q92144007 | FFF-VMAT for SBRT of lung lesions: Improves dose coverage at tumor-lung interface compared to flattened beams |
| Q34355113 | Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors |
| Q40116176 | Influence of different treatment techniques and clinical factors over the intrafraction variation on lung stereotactic body radiotherapy. |
| Q40996938 | Is internal target volume accurate for dose evaluation in lung cancer stereotactic body radiotherapy? |
| Q41856048 | Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy |
| Q47149089 | Low and medium doses of hypofractionated stereotactic radiotherapy could be suboptimal for early-stage lung cancer |
| Q33603813 | Management of three-dimensional intrafraction motion through real-time DMLC tracking |
| Q33758565 | No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236 |
| Q34167597 | Non-surgical management of stage I lung cancer |
| Q30484881 | Normal tissue toxicity after small field hypofractionated stereotactic body radiation |
| Q52838114 | Oligometastases of Gastrointestinal Cancer Origin. |
| Q59587525 | Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy |
| Q30426369 | Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review |
| Q29248453 | Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC |
| Q55002029 | Perspectives on stereotactic body radiotherapy for early-stage non-small cell lung cancer: a maturing treatment modality. |
| Q35036765 | Pneumomediastinum as a complication of SABR for lung metastases |
| Q64072724 | Potential reduction of lung dose via VMAT with jaw tracking in the treatment of single-isocenter/two-lesion lung SBRT |
| Q41067520 | Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy |
| Q26851601 | Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients |
| Q38256158 | Radiation pneumonitis after stereotactic radiation therapy for lung cancer |
| Q46419590 | Radiation safety issues with positron-emission/computed tomography simulation for stereotactic body radiation therapy |
| Q30857091 | Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer |
| Q36326883 | Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors |
| Q40010886 | Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study |
| Q49201909 | Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer |
| Q80100945 | Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors |
| Q37450582 | Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases |
| Q30241812 | Specific toxicity after stereotactic body radiation therapy to the central chest : A comprehensive review |
| Q91742496 | Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review |
| Q42079167 | Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma |
| Q36286591 | Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours |
| Q44020055 | Stereotactic ablative radiotherapy for small lung tumors with a moderate dose. Favorable results and low toxicity |
| Q57172947 | Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances |
| Q60912983 | Stereotactic body radiation therapy for non-small cell lung cancer: A review |
| Q36105945 | Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation |
| Q37420376 | Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer |
| Q90041948 | Stereotactic body radiation therapy in primary hepatocellular carcinoma: current status and future directions |
| Q37649474 | Stereotactic body radiation therapy: a novel treatment modality |
| Q38560967 | Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients |
| Q84146368 | Stereotactic body radiotherapy for lung tumors at the pulmonary hilum |
| Q26781806 | Stereotactic body radiotherapy in lung cancer: an update |
| Q35824255 | Stereotactic radiotherapy for early stage non-small cell lung cancer |
| Q44641177 | Stereotactic radiotherapy for lung cancer using a flattening filter free Clinac |
| Q34004315 | Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). |
| Q37303441 | Successful treatment of triple primary tumor |
| Q26748296 | Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more |
| Q42112356 | Technical note: Correlation of respiratory motion between external patient surface and internal anatomical landmarks |
| Q30443893 | The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy |
| Q26770254 | The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions |
| Q40209055 | The dosimetric effect of inhomogeneity correction in dynamic conformal arc stereotactic body radiation therapy for lung tumors |
| Q35050966 | Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer |
| Q39371182 | Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer |
| Q37589200 | Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials |
| Q26853124 | Treatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy? |
| Q58584561 | Treatment-Related Adverse Effects in Lung Cancer Patients after Stereotactic Ablative Radiation Therapy |
Search more.